Fateme Haghiralsadat

Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy

Ashraf Alemi, Javad Zavar Reza, Fateme Haghiralsadat et al. · Journal of Nanobiotechnology · 2018 · 189 citations · Full text

Co-delivery of hydrophilic and hydrophobic anticancer drugs using biocompatible pH-sensitive lipid-based nano-carriers for multidrug-resistant cancers

Samira Naderinezhad, Ghassem Amoabediny, Fateme Haghiralsadat · RSC Advances · 2017 · 124 citations · Full text

Lipid Preparation, Nanomedicine, Multidrug-resistant Cancers +12

A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery

Fateme Haghiralsadat, Ghassem Amoabediny, Marco N. Helder et al. · Artificial Cells Nanomedicine and Biotechnology · 2017 · 99 citations · Full text

Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy

Mahdie Hemati, Fateme Haghiralsadat, Fatemeh Yazdian et al. · Artificial Cells Nanomedicine and Biotechnology · 2018 · 96 citations · Full text

Nanotherapeutics, Engineering, Therapeutic Response +22

MXene-based cytosensor for the detection of HER2-positive cancer cells using CoFe2O4@Ag magnetic nanohybrids conjugated to the HB5 aptamer

Fereshteh Vajhadin, Mohammad Mazloum‐Ardakani, Maryamsadat Shahidi et al. · Biosensors and Bioelectronics · 2021 · 85 citations

Mxene-based Cytosensor, Engineering, Biomedical Diagnostics +9